PT-141 — Research Summary
PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide derived from melanotan II, specifically engineered for in-vitro research applications. This melanocortin receptor agonist demonstrates selective binding affinity for MC3R and MC4R receptors, making it valuable for researchers investigating neurological signalling pathways and peptide-receptor interactions. The 20mg vial format from Nouveaux provides researchers with sufficient material for comprehensive laboratory studies. Scientists worldwide utilise PT-141 in controlled research environments to examine melanocortin system functionality and cellular response mechanisms. Researchers at Stroid UK Shop can access this compound alongside other research-grade peptides for comparative analysis.
Scientific Research Applications
Laboratory investigations with PT-141 focus on melanocortin receptor binding studies and neuronal pathway analysis. Research teams examine how this peptide interacts with hypothalamic neurons and influences intracellular signalling cascades. Studies investigate PT-141’s selective receptor binding properties compared to other melanocortin agonists available in our endurance drugs and peptides category. Researchers analyse dose-response relationships in cell culture models and evaluate receptor selectivity patterns. Comparative studies examine PT-141 alongside other peptides in our peptides collection to understand structural-activity relationships. Advanced research protocols investigate this compound’s stability profile and optimal storage conditions for laboratory use. Scientists also study PT-141’s interaction with various buffer systems and its compatibility with different analytical techniques used in peptide research. Some laboratories combine PT-141 research with SARMs studies to examine different receptor pathways simultaneously.
Technical Specifications
| Parameter | Specification |
|---|---|
| Peptide Name | PT-141 (Bremelanotide) |
| Manufacturer | Nouveaux |
| Quantity | 20mg per vial |
| Purity | Verify with supplier |
| Molecular Formula | C50H68N14O10 |
| Molecular Weight | 1025.16 g/mol |
| Storage | -20°C, protected from light |
| Solubility | Water soluble |
Research Compliance Statement
PT-141 20mg Nouveaux is manufactured exclusively for in-vitro laboratory research applications. This product is not intended for human consumption, therapeutic use, or any non-research purposes. Researchers must ensure proper laboratory protocols, safety equipment, and waste disposal procedures when handling this compound. All studies should be conducted in appropriate research facilities with qualified personnel.
